Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Analysis of Intestinal Microbiome and Autoimmune Panels as Predictors of Toxicity in ImmunOncology Patients

NCT04107311 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT04107311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04107311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Analysis of Intestinal Microbiome and Autoimmune Panels as Predictors of Toxicity in ImmunOncology Patients
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Active, not recruiting
Start date
September 5, 2019
Completion date
March 5, 2027
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor